Skip to main content

NASA, NIH Award BSI Proteomics $800,000 in SBIR Grants

NEW YORK, Oct. 19 - BSI Proteomics has been awarded three Small Business Innovation Research grants from the National Institutes for Health and NASA totaling $800,000, the company said on Friday.  

BSI will use the money—$700,000 from the space agency and $100,000 from the NIH—to continue developing its Dynamically Controlled Crystallization System, or DCCS, platforms, according to the firm.  

The awards bring to $4 million that BSI Proteomics has won in SBIR grants to date.

NIH approved its grant for BSI to develop its Automated Robotics Dynamically Controlled Crystallization System, also known as ARD, for high-throughput protein screening. Both the ARD and the DCCS platforms let the company “initiate, control, and monitor the entire protein crystallization process,” which BSI says can solve the “protein crystal bottleneck.”

NASA’s contribution, meanwhile, will be allocated to grow aboard the International Space Station Target Orphan Proteins that cannot be crystallized on Earth. A new BSI technology platform, the DCCS2, is currently under development and is earmarked for this project.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.